May 27, 2026
Medically Reviewed by Dr. Sunita Tandulwadkar | Written by ALIV
The Indian Council of Medical Research estimates that over 200 million Indians live with hypertension. In urban centres like Pune and Mumbai — where work stress, salt-rich diets, sedentary routines, and disrupted sleep conspire against cardiovascular health — hypertension has become an almost expected finding at routine checkups. Many of these individuals are also interested in IV therapy for fatigue, immunity, or skin health. The question of whether their blood pressure creates a meaningful clinical risk or simply a consideration to be managed is important and worth understanding clearly.
Every IV infusion adds fluid volume to the circulatory system — typically 250 to 500mL over the course of a session. In a healthy cardiovascular system, this additional volume is handled effortlessly: the heart adjusts slightly, the kidneys begin filtering it, and the body returns to baseline within hours. In patients with poorly controlled hypertension, significant cardiac dysfunction, or compromised kidney function, even moderate additional fluid volume can increase vascular stress. This is not a reason to categorically exclude hypertensive patients from IV therapy — it is a reason to assess carefully before proceeding and to monitor actively throughout.
Magnesium. The most relevant ingredient from a blood pressure perspective — and the one that is almost universally present in standard IV therapy formulations. Magnesium has a vasodilatory effect: it relaxes vascular smooth muscle, which lowers peripheral resistance and reduces blood pressure. At the doses used in IV wellness therapy, this effect is modest but real. For hypertensive patients, this is generally beneficial — there is a reasonable evidence base supporting magnesium supplementation for blood pressure management, including a 2016 meta-analysis in Hypertension showing modest but consistent blood-pressure-lowering effects from magnesium supplementation. The caveat: in patients on calcium channel blockers, the combined vasodilatory effect can be more pronounced and warrants monitoring.
High-dose niacin (vitamin B3). The niacin flush produces transient vasodilation — brief, peripheral, self-limiting. In most hypertensive patients, this is inconsequential. In patients with significant labile blood pressure or those whose pressure is difficult to control, the brief vasodilation can cause a transient dip that may be noticeable. This does not typically require intervention beyond monitoring, but it is worth knowing about.
High-sodium IV carrier fluids. Normal saline (0.9% NaCl) delivers 154 mmol/L of sodium — a consideration for patients with sodium-sensitive hypertension or those on strict sodium restriction. For patients where sodium load is a clinical concern, alternative low-sodium carrier options can be discussed with your ALIV doctor.
At ALIV's Pune and Mumbai clinics, blood pressure is checked at the beginning and end of every IV session for all patients — not just those with known hypertension. This is standard monitoring, not a response to an identified problem. For patients with confirmed hypertension:
If blood pressure is significantly elevated on the day of the session (above 160/100 mmHg as a general threshold), elective IV therapy is deferred. This is not a punitive policy — it is clinical judgement. Proceeding with an IV infusion that adds fluid volume and vasodilatory compounds when blood pressure is already high creates unnecessary risk. The recommendation is to contact the patient's treating physician, ensure blood pressure is better controlled, and reschedule when it is appropriate to proceed.
For patients with controlled hypertension on medication — blood pressure in target range on a stable medication regimen — IV therapy is manageable with the standard monitoring in place. The formulation is reviewed to ensure appropriate carrier fluid choice and to consider whether the magnesium dose requires adjustment based on the patient's specific antihypertensive medications.
Generally yes — controlled hypertension on a stable medication regimen is not a contraindication to IV therapy at ALIV. Disclose all your blood pressure medications at your assessment so our clinical team can review potential interactions with IV formulation ingredients. Blood pressure is monitored before and after every session as standard practice.
IV magnesium has documented, modest blood-pressure-lowering effects and is used in hospital settings for hypertensive emergencies at doses significantly higher than those used in wellness IV therapy. At the wellness doses used at ALIV, the blood-pressure effect is real but modest — a supportive element in a comprehensive blood pressure management plan, not a replacement for antihypertensive medication or the lifestyle changes that remain the cornerstone of long-term blood pressure control.
Your ALIV nurse will be monitoring blood pressure throughout the session. If a significant rise is detected, the infusion rate is reduced and a clinical assessment is done before proceeding. If blood pressure does not respond to rate reduction, the session is paused. At ALIV, the ability to manage this in real time is part of why physician prescription and active clinical monitoring are non-negotiable components of every session.
No — do not skip or delay your antihypertensive medications before a session. Take them at their normal times. Your ALIV doctor will advise if any specific medication timing needs adjustment relative to your IV session — this is only occasionally relevant and will be specifically communicated if applicable.
For the large majority of hypertensive patients, the sodium content of a standard 250–500mL normal saline infusion does not produce a clinically meaningful blood pressure effect. For patients with severe sodium sensitivity or very tight sodium restriction, the ALIV clinical team can discuss alternative carrier options at your assessment.
ALIV's clinical team in Pune and Mumbai reviews your blood pressure, medications and cardiovascular history before recommending any IV formulation. Visit alivtherapy.in to book your assessment.
Medically Reviewed by Dr. Sunita Tandulwadkar. This article is for informational purposes only and does not constitute medical advice. Therapies offered by ALIV are proprietary, experimental protocols and results vary by individual.